LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 57.18 | 84.90 | 98 | 6963 | 0.0141 | 0.0228 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 57.18 | 84.90 | 1327 | 6963 | 0.1906 | 0.5410 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.88 | 84.90 | 147 | 7291 | 0.0202 | 0.0892 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.88 | 84.90 | 1339 | 7291 | 0.1836 | 0.5362 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.88 | 84.90 | 83 | 7291 | 0.0114 | -0.0035 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 58.88 | 84.90 | 1334 | 7291 | 0.1829 | 0.5353 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 60.59 | 84.90 | 138 | 7641 | 0.0181 | 0.0777 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 60.59 | 84.90 | 1332 | 7641 | 0.1743 | 0.5281 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 60.59 | 84.90 | 97 | 7641 | 0.0127 | 0.0207 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 60.59 | 84.90 | 1349 | 7641 | 0.1765 | 0.5311 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 62.29 | 84.90 | 147 | 7934 | 0.0185 | 0.0875 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 62.29 | 84.90 | 1337 | 7934 | 0.1685 | 0.5237 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 62.29 | 84.90 | 102 | 7934 | 0.0129 | 0.0284 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 62.29 | 84.90 | 1383 | 7934 | 0.1743 | 0.5316 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.99 | 84.90 | 140 | 8212 | 0.0170 | 0.0788 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.99 | 84.90 | 1369 | 8212 | 0.1667 | 0.5243 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.99 | 84.90 | 93 | 8212 | 0.0113 | 0.0139 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 63.99 | 84.90 | 1401 | 8212 | 0.1706 | 0.5296 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.70 | 84.90 | 155 | 8484 | 0.0183 | 0.0949 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.70 | 84.90 | 1377 | 8484 | 0.1623 | 0.5211 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.70 | 84.90 | 105 | 8484 | 0.0124 | 0.0325 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 65.70 | 84.90 | 1436 | 8484 | 0.1693 | 0.5307 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.41 | 84.90 | 149 | 8766 | 0.0170 | 0.0877 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.41 | 84.90 | 1416 | 8766 | 0.1615 | 0.5229 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.41 | 84.90 | 106 | 8766 | 0.0121 | 0.0337 | MN20160318_Q02 | E18 |